Full Text
PCN232 DIVERGENT HTA DECISIONS IN EUROPE FOR ONCOLOGY DRUGS GRANTED BREAKTHROUGH DESIGNATION

Abstract

Authors

B. Borissov

Back to Volume 22, Supplemental S2
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×